FDA Import Refusal 799-1644462-1/21/2 — London Drugs

London Drugs — FEI 3004830242

The FDA refused shipment 799-1644462-1/21/2 from London Drugs (Canada) on Jul 17, 2019. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.